Goldman, Butterwick, Fitzpatrick And Groff

This study tests whether injecting a hyaluronic acid filler (SKINVIVE) into the cheeks can improve skin quality in women aged 25-50 who are losing weight with GLP-1 medications. Researchers will measure changes in fine lines, firmness, and radiance over time. The trial involves 2…

This study tests a special nanodiamond cream (Pavise ECMR) to see if it helps skin heal better after facial laser resurfacing. Eight adults aged 35-70 with moderate to severe wrinkles will use the cream or standard care after laser. Doctors will check for redness, swelling, crust…

This study tests a cosmetic injection called poly-L-lactic acid to see if it can improve loose skin on the belly. It will include 20 women, some taking GLP-1 weight-loss drugs and some not. The goal is to see if the treatment makes the skin look tighter and better.

This study looks at how well an injectable hyaluronic acid gel works for mild-to-moderate facial aging, including volume loss, fine lines, and loose skin. About 100 adults aged 30 to 75 will receive the gel using standard injection methods. The main goal is to see if doctors and …

This study tests a serum called AGE on the skin of post-menopausal women aged 45-65 who are taking GLP-1 medications like Ozempic or Wegovy. Half of the 50 participants are on hormone replacement therapy, half are not. The goal is to see if the serum safely improves skin firmness…

This study aims to find out if adding epinephrine to a standard sclerotherapy solution improves the treatment of small leg veins (spider veins). Twenty adults with spider veins will have each leg treated with a different solution, and doctors will compare how well the veins clear…

This study tests a topical serum (AGE serum) to see if it safely improves signs of skin aging like fine lines, sagging, and dullness. It involves 25 adults aged 25-50 who are not menopausal and have been taking GLP-1 weight-loss drugs (like Ozempic or Wegovy) for at least 6 month…